Elsevier Science Inc.
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
The clinical burden of metabolic dysfunction-associated steatohepatitis (MASH) is well-documented, but its economic burden is less well-described. A new study projects the global clinical, humanistic, and economic impact of MASH over the next two decades, highlighting the urgent need for national and global strategies to reduce its negative impact. The